NCT06138223Recruiting
The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
Source: ClinicalTrials.gov · Last updated 7 May 2026
Brief summary (registry, in English)
The survival of patients with incurable gastroesophageal cancer can extend over a year with anticancer therapy. However, the number of patients with deteriorating quality of life in this patient group steadily decreases over time during the treatment. Potentially reversible causes related to deterioration of quality of life are diminished muscle mass, physical capacity and nutritional status. Therefore, interventions that can target these in order to maintain or improve quality of life are urgently needed. However, it is yet unknown whether improvement of physical capacity and nutritional status improves quality of life in patients with incurable gastroesophageal adenocarcinoma after failure of first-line treatment. Since these patients are in a precarious situation, the benefits and harms of a combined exercise and nutritional intervention should be carefully evaluated.Therefore this study investigates the effect of a combined exercise and nutrition intervention compared to usual care on quality of life in incurable GAC patients after progression upon first-line treatment. A total of 196 patients with metastasized gastroesophageal cancer will be recruited and randomly allocated 1:1 to standard care or standard care plus a combined exercise and nutritional intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- First submitted
- 2 Nov 2023
- Start date
- Jan 2024
- Primary completion date
- Sept 2028
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06138223
What you commit to
- Study type: Interventional
- Planned participants: 196
- From Jan 2024 to the primary completion date, Sept 2028
- 22 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pregnancy.
- Note:
- After one year of recruitment we broadened our inclusion criteria from GAC patients receiving beyond first-line palliative treatment or best supportive care to any patient with recurrence/progression of GAC after curative treatment or irresectable/metastatic disease at diagnosis, regardless of timing or type of palliative treatment and number of lines received. This was done to increase generalizability and offer the intervention earlier in the palliative phase to enhance its benefits. We acknowledge this results in a more heterogeneous group, but we believe also a more representative group.
- The inclusion criterium before broadening was:
- Progressive disease after first-line palliative systemic treatment OR within 6 months after completion of curative treatment (i.e. within six months after neoadjuvant chemoradiation, adjuvant nivolumab, or definitive chemoradiation for esophageal adenocarcinoma or within six months after adjuvant 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) for gastric/esophageal cancer or neoadjuvant FLOT if no adjuvant FLOT was given, or after progression during participation in the LyRICX study). Patients on capecitabine monotherapy who are eligible for oxaliplatin reintroduction can be included, too.
Other illness
- Serious active infection.
- Severe neurologic or cardiac impairment according to the American College of Sports Medicine criteria.
- Uncontrolled severe respiratory insufficiency as determined by the treating clinician or if the patient is dependent on oxygen suppletion in rest or during exercise.
Other
- Unstable bone metastases inducing skeletal fragility as determined by the treating clinician.
- Untreated symptomatic known brain metastasis.
- Too physically active (i.e. \>210 minutes/week of moderate-to-vigorous intentional exercise) or engaging in intense exercise training comparable to the RADICES exercise program.
- Uncontrolled severe pain.
- Any other contraindications for exercise as determined by the treating physician.
- Any circumstances that would impede adherence to study requirements or ability to give informed consent, as determined by the treating clinician.
Who the study is looking for
- Incurable adenocarcinoma of the esophagus or stomach
- Recurrence after treatment with curative intent or irresectable/metastatic disease at primary diagnosis. Inclusion can take place regardless of the plan or the actual initiation of multi-line systemic treatment. (i.e. patients that have already started with anticancer therapy are eligible for inclusion too)\*
- Able and willing to perform the exercise and nutritional program and wear the activity tracker.
- Able and willing to fill out the POCOP/RADICES questionnaires.
- Life expectancy \> 12 weeks.
- Age ≥ 18 years.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (22)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Flevoziekenhuis Coordinator of this site? Confirm its status | Almere Stad | Netherlands | Recruiting |
| Meander Medical Center Coordinator of this site? Confirm its status | Amersfoort | Netherlands | Not yet recruiting |
| Amsterdam UMC Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Recruiting |
| Reinier de Graaf Coordinator of this site? Confirm its status | Delft | Netherlands | Recruiting |
| Catharina Ziekenhuis Coordinator of this site? Confirm its status | Eindhoven | Netherlands | Recruiting |
| Beatrix Hospital Coordinator of this site? Confirm its status | Gorinchem | Netherlands | Recruiting |
| Spaarne Gasthuis Coordinator of this site? Confirm its status | Hoofddorp | Netherlands | Recruiting |
| Frisius Medical Center Coordinator of this site? Confirm its status | Leeuwarden | Netherlands | Recruiting |
| Leiden Universitair Medisch Centrum Coordinator of this site? Confirm its status | Leiden | Netherlands | Recruiting |
| Sint Antonius Hospital Coordinator of this site? Confirm its status | Nieuwegein | Netherlands | Not yet recruiting |
| Radboudumc Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Recruiting |
| Canisius Wilhelmina Ziekenhuis Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Recruiting |
| Laurentius Ziekenhuis Coordinator of this site? Confirm its status | Roermond | Netherlands | Recruiting |
| Bravis Ziekenhuis Coordinator of this site? Confirm its status | Roosendaal | Netherlands | Recruiting |
| Ikazia Ziekenhuis Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Recruiting |
| Erasmus Medical Center Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Recruiting |
| Jeroen Bosch Hospital Coordinator of this site? Confirm its status | 's-Hertogenbosch | Netherlands | Active, not recruiting |
| HagaZiekenhuis Coordinator of this site? Confirm its status | The Hague | Netherlands | Recruiting |
| Elisabeth-TweeSteden Hospital Coordinator of this site? Confirm its status | Tilburg | Netherlands | Recruiting |
| UMC Utrecht Coordinator of this site? Confirm its status | Utrecht | Netherlands | Recruiting |
| Diakonessenhuis Coordinator of this site? Confirm its status | Utrecht | Netherlands | Not yet recruiting |
| Zaans Medical Center Coordinator of this site? Confirm its status | Zaandam | Netherlands | Recruiting |
Related publications
- Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.JNCI Cancer Spectr · 2026 · PMID 41592243
This page is information, not medical advice. Discuss any trial with your doctor.